PATENT CLAIM ANALYSIS

Application Number: 15731991
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["424", "094200"]

Abstract:
The Cloning and Expression of Comosain's Minigene and the Methods and Compositions for treating and/or preventing various types of cancer which comprise administered an effective amount of Glyco-polypeptides and Bioflavonoids such as Comosain, Ananase, Bromelainases, Trypsin, Pepsin, Quercetin, Rutin, Naringenin, Genistein, Hesperetin, etc and/or a mixture thereof.

Claim (Index 6):
6 ). The method of  claim 3 , wherein the Comosain, Bromelainase, Ananase, Pepsin, Trypsin, Quercetin, Rutin, Genistein, Naringenin, Hesperetin, complex have cytotoxic effect (through T-cells, and mononuclear cells), anti-metastatic effect, anti-platelet aggregation, anti-inflammation, and anti-tumor- genesis (anti- proliferation and tumor necrotizing factors=TNF) and effect against various types of cancer cell lines and bacteria in animal and human experiments both in vitro and in vivo, such as breast, colon, lung, ovarian, cervical, uterine cancer, and hepatocellular carcinoma, etc.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 95.0
- Lexical Diversity: 1.37209
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15272826', '14003629', '12861152', '11214831', '10617943']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7133560782420528
- 35 USC 102 Novelty (BERT): 0.5110029459019974
- Combined Prediction Score: 0.6931207650080473
- Mean Citation Score: 172.64342000000005
- Max Citation Score: 186.47795
- Similarity Product: 99.16756811536251

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test